What is Thymuskin?
For more than 30 years, Thymuskin® has been successfully used to fight against thinning hair and was used to not only nourish, reinforce, and strengthen the hair, but also provide essential nutrients for general hair care, all leading to noticeably thicker hair.
Thymuskin® is a simple 2-step hair care system.
- Step 1 Applying a Thymuskin Shampoo.
- Step 2 Applying a Thymuskin Serum Gel.
also recommended by Dermatologists because it is clinically proven and is suitable for both men and women with no reported side effects.
Thymuskin ClassicUsed against all types of thinning hair. Best place to start if you are new to Thymuskin® and just beginning to see thinning hair.
Thymuskin MedUsed against strong thinning hair. For sensitive hair and scalp conditions where balding is already present.
Thymuskin ForteUsed against very strong thinning hair. For intensive treatment due to damaged & exhausted hair and scalp conditions.
Thymuskin Balsam ConditionerHelps care for damaged hair and can also restore hair balance. Specifically designed to work with Thymuskin® 2-STEP system.
Thymuskin Styling GelProvides high-maintenance hair with structure and natural body. It is a 2-in-1 styling gel and hair care product. Specifically designed to work with Thymuskin® 2-STEP system.
Thymuskin RegenerationSupportive in the treatment of seborrhoeic eczema and effective for dandruff. Specifically designed to work with Thymuskin® 2-STEP system.
Thymuskin Hydro GelDermatological moisturizing care & growth promotion after hair transplant.
How It Works
- Prolonging the natural growth cycle by protection from DHT and enzymes.
- Rejuvenation of root hair follicles by activation of keratinocytes
- Advanced stimulation by various thymic peptides.
Types of Hair Loss
Hereditary Hair Loss
Alopecia Androgenetica is the medical term used to refer to hereditary hair loss. Inherited hypersensitivity of the hair follicles to androgens, particularly to DHT (dihydrotestosterone), causes the hair follicles to degenerate progressively.
This affects both men and women, with the main difference being in the way it progresses. The more advanced the degeneration of the hair follicles is, the more severe the hair loss will be. Bald spots should be treated as early as possible. Hair growth can often be reactivated within 3 years after hair falls out. One should also aim to preserve and strengthen existing hair structures in order to prevent future thinning hair.
Diffuse Hair Loss
Alopecia Diffusa refers to severe hair loss on the entire head. It may affect hair growth over the entire body, but is usually restricted to the scalp.
There are different reasons known for the premature transgression from the growth phase (anagen phase) to the hair loss phase (telogen phase). These include high febrile infections, protein, iron, or vitamin deficiencies, hormonal imbalances in women (pregnancy/birth, menopause), liver diseases, and severe operations. Stress, a hectic and high workload, and psychological pressure are also some of the increasingly common causes. Naturally, diffuse hair loss often disappears once the cause is eliminated — but the cause is often unknown and the hair loss therefore persists for many years.
Circular Hair Loss
Circular hair loss, also called Alopecia areata is characterized by distinct, progressive bald spots that can spread over the entire head.
There are progression forms that can result in total hair loss on the head (Alopecia totalis), up to total hair loss on the entire body (Alopecia universalis). The exact causes are still unclear but there is a general assumption that Alopecia areata results from an auto-immune reaction. In this case, there are inflammatory cells at the lower end of the hair follicles that suppress hair growth. Since the hair follicles remain intact, there are always spontaneous remissions, but the baldness persists in the rest of the cases.
Hair Loss through Chemotherapy
Hair loss through chemotherapy, also called Alopecia Medicamentosa. The cytostatic drugs administered during chemotherapy result in the loss of head hair (mostly reversible)
The progression in this case largely depends on the substances used, the dosage, and treatment duration. Cytostatic drugs are a group of drugs used to inhibit cell growth, but with a side effect that affects the activity of hair follicles. Normally, the hair grows back approximately 3 months after completion of the chemotherapy, but there have increasingly been cases of persistent hair growth disorder.
Unfortunately, the topic of hair loss is still often neglected in the context of chemotherapy treatment. The common argument is that hair loss has no life-threatening effects. The psychological effect is completely underestimated. This can adversely affect the immune system in addition to the medication.
Thymuskin® is Clinically Proven
Studies and controlled observational scientific investigations performed on more than 1,000 men and women at dermatology and university clinics in Germany and internationally have verified the effectiveness of Thymuskin on all forms of thinning hair.Learn More
30 Years of Hair Care
Developed by Vita-Cos-Med Klett-Loch GmbH in the 1970s, Thymuskin® quickly became regarded as one of the leading preparations worldwide for counteracting thinning hair and for encouraging the formation of new hair follicles. For more than 30 years, Vita-Cos-Med Klett-Loch GmbH has engaged in research, development and distribution of dermatological hair & skin-care with biologically active thymic peptide agents. In 1976, Vita-Cos-Med Klett-Loch started in the pharmaceutical and cosmetic field and slowly began demonstrating the unique effectiveness of the low molecular thymus hydrolysate GKL-01 in treating androgenetic hair loss.
The patented thymic peptide library GKL-02 is a mimicry of the natural thymic total extract worldwide. Thymic therapies have been used successful in medical practice for decades. Now, the active ingredient GKL-02 allows the application of thymic therapies - without the use of ingredients of animal origin. Further pharmaceutical innovations such as the development of the bovine-free low molecular, statistical thymic peptide library GKL-02 and numerous other pharmaceutical patents and products have followed.